The Polish diabetes registry for adults - A pilot study

Diabetologia Kliniczna

Volumn 1, Issue 1, 2012, Pages 3-11

  Witek, Przemysław W ^a   Wołkow, Paweł ^b   Stancel Mozwiłło, Julita ^a   Wojtyczek, Katarzyna ^a   Sieradzki, Jacek ^a,b   Małecki, Maciej ^a,b  

^a UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Chronic complications of diabetes; Diabetes registry; Treatment of diabetes

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ISOPHANE INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; PIG INSULIN; SHORT ACTING INSULIN; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; ARTICLE; AUTONOMIC NEUROPATHY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DIET; DISEASE DURATION; DISEASE REGISTRY; EUROPEAN UNION; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MEDICAL CARE; MEDICAL HISTORY; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT CARE; PERIPHERAL NEUROPATHY; PILOT STUDY; PRACTICE GUIDELINE; PREGNANCY DIABETES MELLITUS; PREVALENCE; QUESTIONNAIRE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VITAL SIGN;

EID: 84886696949     PISSN: 20844441     EISSN: 22992529     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004. 27:1047-1053. (Pubitemid 38579764)
2. Gu K., Cowie C.C., Harris M.I. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 1998; 21: 1138-1145. (Pubitemid 28368522)
3. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008; 31: 596-615.
4. The Diabetes Control and Complications Trial Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal Of Medicine 1993; 329: 977-986.
5. United Kingdom Prospective Diabetes Study Group: Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes. Lancet 1998; 352: 837-848.
6. Nathan D.M., Cleary P.A., Backlund J.Y. i wsp.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 2005; 353: 2643-2653.
7. Duckworth W., Abraira C., Moritz T. i wsp.; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 2009; 360: 129-139.
8. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein H.C., Miller M.E., Byington R.P. i wsp. Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 2008; 358: 2545-2559. (Pubitemid 351831356)
9. ADVANCE Collaborative Group, Patel A., MacMahon S., Chalmers J. i wsp. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 2008; 358: 2560-2572. (Pubitemid 351831357)
10. Gaede P., Lund-Andersen H., Parving H.H., Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N. Engl. J. Med. 2008; 358: 580-591. (Pubitemid 351214285)
11. Colhoun H.M., Betteridge D.J., Durrington P.N. i wsp.; CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004; 364: 685-696. (Pubitemid 39140624)
12. Andel M., Grzeszczak W., Michalek J. i wsp.; DEPAC Group. A multinational, multi-centre, observational, cross-sectional survey assessing diabetes secondary care in Central and Eastern Europe (DEPAC Survey). Diabet. Med. 2008; 25: 1195-1203.
13. Eeg-Olofsson K., Cederholm J., Nilsson P.M., Gudbjörnsdóttir S., Eliasson B.; Steering Committee of the Swedish National Diabe tes Register. Glycemic and risk factor control in type 1 diabetes: results from 13,612 patients in a national diabetes register. Diabetes Care 2007; 30: 496-502. (Pubitemid 46354324)
14. Cyganek K., Hebda-Szydlo A., Katra B. i wsp. Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning. Diabetes. Technol. Ther. 2010; 12: 41-47.
15. De Berardis G., Pellegrini F., Franciosi M. i wsp.; QuED Study. Quality of care and outcomes in type 2 diabetic patients: a comparison between general practice and diabetes clinics. Diabetes Care 2004; 27: 398-406. (Pubitemid 38174064)
16. Orozco-Beltrán D., Gil-Guillen V.F., Quirce F. i wsp.; Collaborative Diabetes Study Investigators. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes in primary care. The gap between guidelines and reality in Spain. Int. J. Clin. Pract. 2007; 61: 909-915. (Pubitemid 46745231)
17. Cheung B.M., Ong K.L., Cherny S.S., Sham P.C., Tso A.W., Lam K.S. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am. J. Med. 2009; 122: 443-453.
18. Bertoni A.G., Clark J.M., Feeney P. i wsp.; Look AHEAD Research Group. Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study. J. Diabetes Complications 2008; 22: 1-9.
19. Ott P., Benke I., Stelzer J., Köhler C., Hanefeld M. Diabetes in Germany (DIG) study. A prospective 4-year-follow-up study on the quality of treatment for type 2 diabetes in daily practice. Dtsch Med. Wochenschr. 2009; 134: 291-297.
20. Charpentier G., Genès N., Vaur L. i wsp.; ESPOIR Diabetes Study Investigators. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey. Diabetes Metab. 2003; 29: 152-158. (Pubitemid 36576094)
21. Eliasson B., Cederholm J., Nilsson P., Gudbjörnsdóttir S.; Steering Committee of the Swedish National Diabetes Register. The gap between guidelines and reality: type 2 diabetes in a National Diabetes Register 1996-2003. Diabet. Med. 2005; 22: 1420-1426. (Pubitemid 41391321)
22. Haffner S.M., Lehto S., Rönnemaa T., Pyörälä K., Laakso M. Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction. N. Engl. J. Med. 1998; 339: 229-234. (Pubitemid 28350165)
23. United Kingdom Prospective Diabetes Study Group: High blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br. Med. J. 1998; 7160: 703-712.
24. Patel A; ADVANCE Collaborative Group, MacMahon S., Chalmers J., Neal B. i wsp. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370: 829-840. (Pubitemid 47362321)
25. Clinical Practice Recommendations. Diabetes Care 2010; 33, suppl. 1.
26. ACCORD Study Group, Cushman W.C., Evans G.W., Byington R.P. i wsp. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N. Engl. J. Med. 2010; 362: 1575-1585.
27. Pedro R.A., Ramon S.A., Marc B.B., Juan F.B., Isabel M.M. Prevalence and relationship between diabetic retinopathy and nephropathy, and its risk factors in the North-East of Spain, a population-based study. Ophthalmic Epidemiol. 2010; 17: 251-265.
28. Heintz E., Wiréhn A.B., Peebo B.B., Rosenqvist U., Levin L.A. Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden. Diabetologia 2010; 53: 2147-2154.
29. Delcourt C., Massin P., Rosilio M. Epidemiology of diabetic retinopathy: expected vs reported prevalence of cases in the French population. Diabetes Metab. 2009; 35: 431-438.
30. Zhang X., Saaddine J.B., Chou C.F. i wsp. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA 2010; 304: 649-656.